Compugen (CGEN) Tops Q2 EPS by 7c

Compugen (NASDAQ: CGEN) reported Q2 EPS of ($0.02), $0.07 better than the analyst estimate of ($0.09). Revenue for the quarter came in at $6.7 million versus the consensus estimate of $2.43 million.

For earnings history and earnings-related data on Compugen (CGEN) click here.

You May Also Be Interested In

• Kalshi in early talks for IPO - The Information
• Grizzly Discoveries closes private placement raising $349,044
• Compugen Presents a Trial-in-Progress Poster on the MAIA-ovarian Adaptive Platform Trial at ESMO Gynaecological Cancers Congress